International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8090650
Original Article
Prevalence of Cardiac autonomic neuropathy in patients with Type 2 diabetes mellitus and Peripheral neuropathy in a Tertiary care teaching hospital in central Kerala
 ,
 ,
 ,
Published
June 28, 2023
Abstract

Background: Diabetes mellitus is a group of metabolic disorders characterized by hyperglycemia. Complex combinations between environmental and genetic factors cause various types of diabetes mellitus. Complications from diabetes mellitus, such as cardiac autonomic neuropathy, are common. Unbalanced autonomic function, which manifests as cardiac autonomic neuropathy, is a significant predictor of cardiovascular events in the diabetic patients.

Objectives: To study the prevalence of cardiac autonomic neuropathy in patients with type 2 diabetes mellitus with peripheral neuropathy in a tertiary care teaching hospital.

Methodology: Observational Cross-sectional hospital-based study done in 131 type 2 diabetes mellitus patients who presented to the General Medicine outpatient and inpatient departments of a tertiary care teaching hospital of central Kerala from December 2020 to April 2022. The data was entered in MS excel sheet and was analyzed using SPSS software.

Results: In the present study the mean age was 62.24 years. Among participants, 96.2% had HbA1c levels above 6.5%. Mean duration of living with diabetes is13.40 years. We observed that 65.6% of the patients in our study population had Cardiac autonomic neuropathy. Despite having peripheral neuropathy, 34.4% of participants exhibited normal cardiac sympathetic and parasympathetic function.

Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
716 Views
165 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved